• PBC Biomed Appoints Mark McMahan as Chief Commercial Officer

    Irish medical device company PBC Biomed today announced the appointment of Mark McMahan as Chief Commercial Officer, effective October 2025. McMahan, formerly Vice President of Global & US Trauma & Extremities Marketing at Smith & Nephew, brings extensive international expertise in medical device commercialization and strategy. In his new role, McMahan will oversee global commercialization…

    Read More...

  • Surgery Summit 2025

    Save the Date – ACVS 2025 | Seattle, WA We’re excited to announce our participation in the ACVS Surgery Summit 2025, taking place this October in Seattle, Washington. Mark your calendar now — more details to follow soon! #ACVS2025 #PBCBioVet #OssiVet #VetSurgery #VeterinaryOrthopedics #BoneAdhesive #VetInnovation #Seattle2025 #SaveTheDate #BiomimeticMaterials

    Read More...

  • Equita Lyon 2025

    Save the date! We’re excited to announce that PBC BioVet will participate in Equita Lyon 2025 from October 29 to November 2, as part of the Enterprise Ireland delegation 🇮🇪 Our goal: to connect with veterinary professionals, distributors, and equine stakeholders in France, and explore new partnerships to expand our business in the French market.…

    Read More...

  • PBC Biomed Support Major Trauma Awareness Week 2025

    ,

    PBC Biomed are supporting Major Trauma Awareness Week 2025! Help us raise awareness of the long and complex road to recover after catastrophic injuries and the role hope and community play in trauma recovery. Find out more: https://lnkd.in/eaqXj_Ki Day One Trauma Support #MTAW25

    Read More...

  • PBC Biomed Poster Presentation at ESB 2025

    , , , , ,

    Congratulations to Senior R&D Engineer Antzela Tzagiollari on her poster presentation at the ESB 2025 event yesterday, highlighting her team’s research on OsStic® as a promising next-generation biomaterial. Their findings show that OsStic® uniquely combines bone adhesion, mechanical strength, and prolonged antibiotic delivery. While incorporating vancomycin reduced its strength, OsStic® still demonstrated clinically acceptable performance.…

    Read More...

  • Day One Trauma Support launch Major Trauma Awareness Week Campaign

    The PBC Biomed team were delighted to attend Day One Trauma Support‘s launch event for their major Trauma Awareness Week Campaign. Thank you to the Day One Trauma team for the invite, and to all of the speakers for sharing their inspiring stories. Proud to sponsor such a fantastic organisation! #MTAW #majortraumaawarenesaweek #charitypartner #pbcbiomed #acceleratingmedicalinnovation

    Read More...

  • First Call for Papers – Bioadhesive Symposium at ESB 2026

    , , , ,

    We are excited to announce our first call for papers for the PBC Biomed #Bioadhesive Symposium, which will be held as part of next year’s ESB Meeting in Antwerp, Belgium. The symposium will be chaired by Prof. Nicholas Dunne (DCU, Ireland) and feature keynote lectures from Prof. Håkan Engqvist (Uppsala University, Sweden), Dr. Marc Bohner…

    Read More...

  • Orthopaedic Trauma Association (OTA) Annual Meeting

    We’re thrilled to be heading back to the Orthopaedic Trauma Association(OTA) Annual Meeting in Phoenix, AZ this October! The main event is Part 4 of the PBC Biomed ‘Strengthening the Bond’Education Program – “Closing the Gap in Fracture Healing: The StoryContinues” on Friday, October 17th at 7am in Theatre D. Our world-class panel of surgeon…

    Read More...

  • American Society for Surgery of the Hand

    Planning for the American Society for Surgery of the Hand is under way! Find us at Booth #903 from October 9–11 in Vancouver, BC, for a ReFeelNerve Repair Solution demo – a simpler and effective nerve treatmentoption. Celebrating one year on the market in the US. Don’t miss out on this opportunity to see what’s…

    Read More...

  • Learn more about PBC Biomed’s collaboration with RTU at ESB 2025

    , ,

    On Monday, 8th September (1:00–2:00pm), Ilijana Kovrlija, RTU Research Associate, will be at our booth to discuss her research and RTU’s joint projects with PBC Biomed. Research being presented by the RTU team at ESB includes: Presentation:Ilijana Kovrlija – Rethinking ISO 10993-5: Enhancing In Vitro Cytotoxicity Assessment for Octacalcium Phosphate, Amorphous Calcium Phosphate, Tricalcium Phosphate…

    Read More...

Connect with us on LinkedIn
Search News Items
Categories